Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1994 Spring;15(3):127-40.

International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom

D J Gross  1 , J Ratner, J Perez, S L Glavin
Affiliations
Comparative Study

International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom

D J Gross et al. Health Care Financ Rev. 1994 Spring.

Abstract

France, Germany, Sweden, and the United Kingdom each use different types of policies for controlling prescription drug spending. Until recent years, these policies have relied heavily on regulating prices charged by drug manufacturers, with different systems providing varying degrees of pricing freedom. While these policies appear to have brought some degree of price restraint, they have not prevented continued growth in prescription drug spending. As a result, each country is supplementing its policies with measures aimed at physicians and consumers and targeted at reducing a perceived over-utilization of pharmaceutical products.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Pharmaceutical Expenditures as Percent of Total National Health Care Costs: 1990
Figure 2
Figure 2. Pharmaceutical Price Changes: 1985–91
Figure 3
Figure 3. Pharmaceutical Expenditure Growth1:1985–90
1Inflation-adjusted. 2United Kingdom data are for the period 1985–89. SOURCE: Organization for Economic Cooperation and Development: OECD Health Data file 1993.
Figure 4
Figure 4. Growth in Utilization and Prices: 1985–90
See this image and copyright information in PMC

References

    1. Association Belge des Consommateurs. Statement prepared for the United States Senate Special Committee on Aging. Washington DC.: 1989.
    1. Berndt ER, Griliches Z, Rosett J. Auditing the Producer Price Index: Micro Evidence from Prescription Pharmaceutical Preparations. Washington, DC.: National Bureau of Economic Research; 1992. Working Paper No. 4009.
    1. Letsch SW. National Health Care Spending in 1991. Health Affairs. 1993;12:94–110. - PubMed
    1. Redwood H. Price Regulation and Pharmaceutical Research: The Limits of Coexistence. Suffolk, England: Oldwicks Press Limited; 1993.
    1. Reekie WD. Drug Prices in the UK, USA, Europe, and Australia. Australian Economic Papers. 1984 Jun;:71–78.

Publication types

MeSH terms

LinkOut - more resources